Use of heat therapy for the management of musculoskeletal pain in the community pharmacy: New FIP guidance

Musculoskeletal (MSK) pain is a common condition affecting millions of people, resulting in reduced quality of life and increased healthcare costs. Community pharmacists play a vital role as the first point of contact for patients seeking relief from MSK pain. In recognition of the Global Day Against Pain, this event will launch a new FIP guidance focused on enhancing the management of MSK pain in pharmacies. The guidance highlights the use of heat therapy, both as a stand-alone treatment and in combination with other therapies. Attendees will learn about types and symptoms of MSK pain, the mechanism of heat therapy, and effective patient assessment and management strategies in the pharmacy setting.

Moderator: - Sherif Guorgui, President, FIP Community Pharmacy Section, Canada

Panellists: - Nisa Masyitah, FIP Project and Data Support Coordinator International Pharmaceutical Federation (FIP), Indonesia

- Philip Conaghan, Director, NIHR Leeds Biomedical Research Centre University of Leeds, United Kingdom

- Zanoli Gustavo, Orthopaedic Surgeon Casa Di Cura Santa Maria Maddalena, Occhiobello, Italy

- Opeyemi Babatunde, Senior Lecturer: Evidence Synthesis and Applied Health Research School of Medicine, Primary Care Centre Versus Arthritis Keele University, Keele, Staffordshire, United Kingdom

- Ema Paulino, President National Pharmacy Association (ANF), Portugal